Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation

BACKGROUND: Shikonin (SKN), a naphthoquinone compound, is isolated from Chinese herbal medicine Lithospermum root and has been studied as an anticancer drug candidate in human tumor models. This study is designed to investigate whether SKN can sensitize the therapeutic effect of paclitaxel (PTX) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhu, Yin, Jianhua, Li, Mingxing, Shen, Jing, Xiao, Zhangang, Zhao, Yueshui, Huang, Chengliang, Zhang, Hanyu, Zhang, Zhuo, Cho, Chi Hin, Wu, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417206/
https://www.ncbi.nlm.nih.gov/pubmed/30911326
http://dx.doi.org/10.1186/s13020-019-0231-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417206/
https://www.ncbi.nlm.nih.gov/pubmed/30911326
http://dx.doi.org/10.1186/s13020-019-0231-3

Ejemplares similares